Thyrotropin receptor-stimulating Graves' disease immunoglobulins induce hyaluronan synthesis by differentiated orbital fibroblasts from patients with Graves' ophthalmopathy not only via cyclic adenosine monophosphate signaling pathways.

BACKGROUND Both expression of the thyrotropin receptor (TSHR) and the production of hyaluronan (HA) by orbital fibroblasts (OF) have been proposed to be implicated in the pathogenesis of Graves' ophthalmopathy (GO). HA is synthesized by three types of HA synthase. We hypothesized that TSHR activation by recombinant human TSH (rhTSH) and TSHR-stimulating Graves' disease immunoglobulins (GD-IgGs) via induced cyclic adenosine monophosphate (cAMP) signaling increases HA synthesis in differentiated OF from GO patients. METHODS Cultured human OF, obtained during decompression surgery from 17 patients with severe GO, were stimulated in vitro to differentiate into adipocytes. Differentiation was evaluated by phase-contrast microscopy. The differentiated OF were stimulated by rhTSH or by TSHR-stimulating GD-IgG. We measured cAMP using a biochemical assay, HA synthase mRNA expression by quantitative polymerase chain reaction, and HA in the supernatant by enzyme-linked immunosorbent assay. RESULTS All differentiated OF cultures expressed higher levels of TSHR mRNA than nondifferentiated OF cultures. Stimulation by rhTSH induced a marked cAMP response in 11 of 12 differentiated OF cultures, but no measurable HA response in all but one differentiated OF cultures. By contrast, stimulation by GD-IgG induced a moderate cAMP response in a number of differentiated OF cultures, but a marked HA response in the majority of differentiated OF cultures. CONCLUSION Stimulation of differentiated OF by GD-IgG, but not by rhTSH, induces HA synthesis in the majority of patients, suggesting that in most patients TSHR-mediated cAMP signaling does not play a pivotal role in GD-IgG-induced HA synthesis in differentiated OF cultures.

[1]  E. Fliers,et al.  Effects of thyrotropin and thyrotropin-receptor-stimulating Graves' disease immunoglobulin G on cyclic adenosine monophosphate and hyaluronan production in nondifferentiated orbital fibroblasts of Graves' ophthalmopathy patients. , 2010, Thyroid : official journal of the American Thyroid Association.

[2]  M. Schott A Stimulatory Thyrotropin Receptor Antibody (M22) and Thyrotropin Increase Interleukin-6 Expression and Secretion in Graves' Orbital Preadipocyte Fibroblasts , 2010 .

[3]  R. Bahn Graves' ophthalmopathy. , 2010, The New England journal of medicine.

[4]  S. Rauz,et al.  The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  M. Ludgate,et al.  Thyrotropin Receptor Activation Increases Hyaluronan Production in Preadipocyte Fibroblasts , 2009, The Journal of Biological Chemistry.

[6]  R. Latif,et al.  Characterization of thyrotropin receptor antibody-induced signaling cascades. , 2009, Endocrinology.

[7]  Terry J. Smith,et al.  Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. , 2008, Thyroid : official journal of the American Thyroid Association.

[8]  Jan Kelder,et al.  A signaling-selective, nanomolar potent allosteric low molecular weight agonist for the human luteinizing hormone receptor , 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  S. Feldon,et al.  Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. , 2006, The American journal of pathology.

[10]  N. Morgenthaler,et al.  Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. , 2006, The Journal of clinical endocrinology and metabolism.

[11]  C. Marcocci,et al.  Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation. , 2005, European journal of endocrinology.

[12]  M. Mummert Immunologic roles of hyaluronan , 2005, Immunologic research.

[13]  Terry J. Smith,et al.  Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor. , 2004, The Journal of clinical endocrinology and metabolism.

[14]  M. Ludgate,et al.  Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. , 2003, Journal of molecular endocrinology.

[15]  W. Wiersinga,et al.  TSH‐R expression and cytokine profile in orbital tissue of active vs. inactive Graves’ ophthalmopathy patients , 2003, Clinical endocrinology.

[16]  R. Bahn,et al.  Stimulation of adipogenesis, peroxisome proliferator-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts , 2002 .

[17]  R. Bahn,et al.  Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. , 2002, The Journal of clinical endocrinology and metabolism.

[18]  M. Crisp,et al.  Adipogenesis in thyroid eye disease. , 2000, Investigative ophthalmology & visual science.

[19]  A. Sorisky,et al.  Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. , 2000, American journal of physiology. Cell physiology.

[20]  P. Heldin,et al.  Expression of human hyaluronan synthases in response to external stimuli. , 2000, The Biochemical journal.

[21]  M. Gerding,et al.  Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy , 2000, Clinical endocrinology.

[22]  A. Weetman,et al.  Graves' disease , 1988 .

[23]  T. Smith,et al.  Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1beta in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy. , 1999, The Journal of clinical endocrinology and metabolism.

[24]  S. Jyonouchi,et al.  Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. , 1999, The Journal of clinical endocrinology and metabolism.

[25]  B. Rapoport,et al.  The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies , 1998 .

[26]  Terry J. Smith,et al.  Activation of Human Orbital Fibroblasts through CD40 Engagement Results in a Dramatic Induction of Hyaluronan Synthesis and Prostaglandin Endoperoxide H Synthase-2 Expression , 1998, The Journal of Biological Chemistry.

[27]  B. Rapoport,et al.  The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. , 1998, Endocrine reviews.

[28]  Terry J. Smith,et al.  Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. , 1997, The American journal of pathology.

[29]  W. Wiersinga,et al.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy , 1997, Clinical endocrinology.

[30]  A. Sorisky,et al.  Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture. , 1996, The Journal of clinical endocrinology and metabolism.

[31]  T. Smith,et al.  Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts. , 1995, The American journal of physiology.

[32]  Y. Shishiba,et al.  Effects of dibutyryl cyclic AMP on hyaluronan and proteoglycan synthesis by retroocular tissue fibroblasts in culture. , 1994, Endocrine journal.

[33]  C. Gorman,et al.  Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblasts. , 1991, The Journal of clinical endocrinology and metabolism.

[34]  G. Woloschak,et al.  Human retroocular fibroblasts in vitro: a model for the study of Graves' ophthalmopathy. , 1987, The Journal of clinical endocrinology and metabolism.

[35]  M. Namba,et al.  Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction , 1987, The Journal of cell biology.

[36]  J. Hopwood,et al.  Absence of hyaluronidase in cultured human skin fibroblasts. , 1975, Biochemical and biophysical research communications.

[37]  R. Tobey,et al.  CELL-CYCLE DEPENDENT DESQUAMATION OF HEPARAN SULFATE FROM THE CELL SURFACE , 1972, The Journal of cell biology.